SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/A0C4968D63848F27A4C1D83F7E192E38513054890895DF15DC77DEC36CBDF594AE6AEA0FB3B2DF054082093291723766>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/A0C4968D63848F27A4C1D83F7E192E38513054890895DF15DC77DEC36CBDF594AE6AEA0FB3B2DF054082093291723766
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/A0C4968D63848F27A4C1D83F7E192E38513054890895DF15DC77DEC36CBDF594AE6AEA0FB3B2DF054082093291723766
http://www.w3.org/2000/01/rdf-schema#comment
"HepG2-CD133+ cells possess higher capacity for tumorigenicity."
xsd:string
http://purl.uniprot.org/uniprot/#_22A68FE8B5D1C929C65C453BDD49F21F020663D5F7302062E82DEDC9ED7B8BD7F1B81E04A475731288AE01E1577D940F
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/A0C4968D63848F27A4C1D83F7E192E38513054890895DF15DC77DEC36CBDF594AE6AEA0FB3B2DF054082093291723766
http://purl.uniprot.org/uniprot/O43490
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/A0C4968D63848F27A4C1D83F7E192E38513054890895DF15DC77DEC36CBDF594AE6AEA0FB3B2DF054082093291723766
http://purl.uniprot.org/uniprot/#_O43490-mappedCitation-23233126
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/A0C4968D63848F27A4C1D83F7E192E38513054890895DF15DC77DEC36CBDF594AE6AEA0FB3B2DF054082093291723766